The Journal of Cancer Research (JCR) is an international, peer-reviewed, open-access journal that aims to serve as a comprehensive platform for the advancement of cancer science and medicine. The journal is devoted to publishing impactful research that deepens our understanding of cancer biology, enhances clinical practice, and fosters innovation in cancer prevention, diagnosis, and therapy.

✦ Aim:

Our primary aim is to accelerate the global fight against cancer by providing a reliable forum for the dissemination of original discoveries, translational studies, and clinical evidence. By connecting basic research with applied sciences, we strive to support the development of effective strategies that improve patient survival, quality of life, and long-term outcomes.

✦ Scope:

The journal welcomes contributions across the broad spectrum of oncology, including but not limited to:

• Cancer Biology & Genetics: Mechanisms of carcinogenesis, molecular signaling pathways, gene regulation, epigenetics, and tumor microenvironment.
• Immunology & Immunotherapy: Advances in tumor immunology, immune checkpoints, cancer vaccines, cell-based therapies, and immune biomarkers.
• Diagnostics & Biomarkers: Innovative tools for early detection, molecular diagnostics, imaging techniques, and prognostic indicators.
• Therapeutics & Clinical Research: Chemotherapy, targeted therapy, radiotherapy, surgical oncology, clinical trials, and novel treatment approaches.
• Precision & Personalized Medicine: Genomic profiling, individualized therapy strategies, and real-world applications in oncology.
• Epidemiology & Public Health: Cancer incidence, risk factors, prevention strategies, screening programs, and population-based studies.
• Translational Research: Bridging laboratory discoveries with clinical practice to improve patient care.
• Cancer Care & Survivorship: Palliative care, psychosocial support, rehabilitation, and long-term follow-up of cancer survivors.

✦ Audience:

The journal caters to oncologists, researchers, clinicians, surgeons, pathologists, molecular biologists, public health specialists, and policymakers dedicated to reducing the global burden of cancer.

By embracing an interdisciplinary approach, JCR strives to become a valuable resource for the scientific community, promoting innovation and collaboration to advance cancer research worldwide.